HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Use of monoclonal antibodies in detection of melanoma-associated antigens in intact human tumors.

Abstract
The use of antimelanoma monoclonal antibodies on tissue sections using a two-step indirect immunoperoxidase technique is reported. Antibodies 691-13-17 and 691-I5-Nu4B reacted with dysplastic nevus cells and all melanomas tested, but not with normal skin melanocytes, intradermal nevi, or lentigines. Antibody 691-13-17, directed against DR antigen, reacted also with Langerhan's cells, macrophages, and a subpopulation of lymphocytes. Antibody 691-I5-Nu4B reacted only with melanomas. The technique allows analysis of the expression of antigens by tumor cells in situ.
AuthorsJ J Thompson, M F Herlyn, D E Elder, W H Clark, Z Steplewski, H Koprowski
JournalThe American journal of pathology (Am J Pathol) Vol. 107 Issue 3 Pg. 357-61 (Jun 1982) ISSN: 0002-9440 [Print] United States
PMID6177248 (Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antibodies, Monoclonal
  • Antigens, Neoplasm
Topics
  • Adult
  • Aged
  • Antibodies, Monoclonal (immunology)
  • Antibody Specificity
  • Antigens, Neoplasm (analysis)
  • Female
  • Humans
  • Immunoenzyme Techniques
  • Lymphatic Metastasis
  • Male
  • Melanoma (diagnosis, immunology)
  • Middle Aged
  • Skin Neoplasms (diagnosis, immunology)
  • Staining and Labeling

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: